Yabal, M.* ; Müller, N.* ; Adler, H. ; Knies, N.* ; Groß, C.J.* ; Damgaard, R.B.* ; Kanegane, H.* ; Ringelhan, M. ; Kaufmann, T.* ; Heikenwälder, M. ; Strasser, A.* ; Groß, O.* ; Ruland, J.* ; Peschel, C.* ; Gyrd-Hansen, M.* ; Jost, P.J.*
XIAP restricts TNF- and RIP3-dependent cell death and inflammasome activation.
Cell Rep. 7, 1796-1808 (2014)
X-linked inhibitor of apoptosis protein (XIAP) has been identified as a potent regulator of innate immune responses, and loss-of-function mutations in XIAP cause the development of the X-linked lymphoproliferative syndrome type 2 (XLP-2) in humans. Using gene-targeted mice, we show that loss of XIAP or deletion of its RING domain lead to excessive cell death and IL-1β secretion from dendritic cells triggered by diverse Toll-like receptor stimuli. Aberrant IL-1β secretion is TNF dependent and requires RIP3 but is independent of cIAP1/cIAP2. The observed cell death also requires TNF and RIP3 but proceeds independently of caspase-1/caspase-11 or caspase-8 function. Loss of XIAP results in aberrantly elevated ubiquitylation of RIP1 outside of TNFR complex I. Virally infected Xiap(-/-) mice present with symptoms reminiscent of XLP-2. Our data show that XIAP controls RIP3-dependent cell death and IL-1β secretion in response to TNF, which might contribute to hyperinflammation in patients with XLP-2.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Nf-kappa-b; Linked Lymphoproliferative Syndrome; Alpha-dependent Apoptosis; Hemophagocytic Lymphohistiocytosis; Programmed Necrosis; Immune-response; Deficiency; Disease; Complex; Iaps
Keywords plus
Language
english
Publication Year
2014
Prepublished in Year
HGF-reported in Year
2014
ISSN (print) / ISBN
2211-1247
e-ISSN
2211-1247
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 7,
Issue: 6,
Pages: 1796-1808
Article Number: ,
Supplement: ,
Series
Publisher
Cell Press
Publishing Place
Cambridge
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
Research field(s)
Immune Response and Infection
PSP Element(s)
G-501500-006
G-551600-001
Grants
Copyright
Erfassungsdatum
2014-06-04